Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Non-Current Liabilities (2022 - 2025)

PAVmed has reported Total Non-Current Liabilities over the past 4 years, most recently at $927000.0 for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $927000.0 for Q4 2025, down 48.5% from a year ago — trailing twelve months through Dec 2025 was $927000.0 (down 48.5% YoY), and the annual figure for FY2025 was $927000.0, down 48.5%.
  • Total Non-Current Liabilities for Q4 2025 was $927000.0 at PAVmed, down from $1.2 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for PAVM hit a ceiling of $57.6 million in Q3 2023 and a floor of $927000.0 in Q4 2025.
  • Median Total Non-Current Liabilities over the past 4 years was $2.0 million (2022), compared with a mean of $13.6 million.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 2385.25% in 2023 and later plummeted 86.09% in 2024.
  • PAVmed's Total Non-Current Liabilities stood at $2.2 million in 2022, then surged by 492.62% to $12.9 million in 2023, then plummeted by 86.09% to $1.8 million in 2024, then plummeted by 48.5% to $927000.0 in 2025.
  • The last three reported values for Total Non-Current Liabilities were $927000.0 (Q4 2025), $1.2 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.